| Title |
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, September 2018
|
| DOI | 10.1007/s10549-018-4983-8 |
| Pubmed ID | |
| Authors |
Katharina Smetanay, Philippe Junio, Manuel Feißt, Julia Seitz, Jessica Cecile Hassel, Luisa Mayer, Lina Maria Matthies, Arina Schumann, André Hennigs, Jörg Heil, Christof Sohn, Dirk Jaeger, Andreas Schneeweiss, Frederik Marmé |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 40% |
| Canada | 3 | 30% |
| United Kingdom | 1 | 10% |
| Australia | 1 | 10% |
| Unknown | 1 | 10% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 50% |
| Scientists | 4 | 40% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 96 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 18% |
| Student > Bachelor | 10 | 10% |
| Other | 8 | 8% |
| Student > Postgraduate | 7 | 7% |
| Researcher | 7 | 7% |
| Other | 15 | 16% |
| Unknown | 32 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 28% |
| Nursing and Health Professions | 18 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Economics, Econometrics and Finance | 2 | 2% |
| Business, Management and Accounting | 1 | 1% |
| Other | 6 | 6% |
| Unknown | 37 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2018.
All research outputs
#4,521,850
of 23,106,390 outputs
Outputs from Breast Cancer Research and Treatment
#832
of 4,688 outputs
Outputs of similar age
#89,283
of 341,075 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#17
of 67 outputs
Altmetric has tracked 23,106,390 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,688 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,075 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.